Journal
TUMOR BIOLOGY
Volume 37, Issue 9, Pages 12713-12723Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1007/s13277-016-5146-3
Keywords
4.1N, non-small cell lung cancer (NSCLC); Flotillin-1; Flotillin-1/beta-catenin/Wnt pathway
Categories
Funding
- National Natural Science Foundation of China [81301997, 81301710, 81372538]
Ask authors/readers for more resources
The membrane-cytoskeletal protein 4.1N has recently been proposed as a tumor suppressor in a number of cancers of epithelial origin, including non-small-cell lung cancer (NSCLC). However, the molecular mechanism associated with 4.1N tumor suppression remains has not been thoroughly characterized. In this study, 4.1N was shown to directly interact with the lipid raft marker flotillin-1 through its FERM and U2 domains in several different NSCLC cell lines using immunoprecipitation, co-immunoprecipitation and pull-down assays. Moreover, 4.1N silencing/overexpression experiments in paired 95C/95D cells that are of homologous origin but varying endogenous 4.1N expression (high expression in 95C cells, low expression in 95D cells) indicated that 4.1N is involved in the suppression of cell proliferation and migration through a flotillin-1/beta-catenin/Wnt pathway. Taken together, the findings of this study help to elucidate the novel tumor suppressor role of 4.1N in NSCLC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available